Fulcrum Therapeutics FULC
NASDAQ FULC
$3.69 -0.01 (-0.27%)
As of: Sep 30, 2026 · 3:59 PM EDT

Fulcrum Therapeutics (FULC) Total Non-Current Liabilities (2018 - 2026)

Updated

Fulcrum Therapeutics (FULC) posted Total Non-Current Liabilities of $13.06 million for Q2 2026, down 8.4% from $14.26 million a year earlier and down 1.6% from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Fulcrum Therapeutics' Total Non-Current Liabilities came in at $17.09 million, down 2.3% from FY2024.

  • Annual Total Non-Current Liabilities has declined for three consecutive years, with a five-year compound annual growth rate of -11.4% (FY2020 to FY2025).
  • In prior years, Fulcrum Therapeutics' Total Non-Current Liabilities was $17.49 million in FY2024 (-21.6%), $22.3 million in FY2023 (-19.0%), $27.55 million in FY2022 (+31.9%) and $20.88 million in FY2021 (-33.4%).
  • The Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since Q3 2019.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last 14 quarters, with an average decline of 15.5% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2022, with growth of 41.8%; the weakest was Q3 2021, with a decline of 34.7%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $13.27 million (Q1 2026), $17.09 million (Q4 2025) and $16.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Fulcrum Therapeutics 282.26 Mn 282.26 Mn - 13.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.06 Mn
Mar 31, 2026 13.27 Mn
Dec 31, 2025 17.09 Mn
Sep 30, 2025 16.30 Mn
Jun 30, 2025 14.26 Mn
Mar 31, 2025 13.97 Mn
Dec 31, 2024 17.49 Mn
Sep 30, 2024 21.52 Mn
Jun 30, 2024 20.27 Mn
Mar 31, 2024 18.80 Mn
Dec 31, 2023 22.30 Mn
Sep 30, 2023 23.22 Mn
Jun 30, 2023 24.46 Mn
Mar 31, 2023 24.54 Mn
Dec 31, 2022 27.55 Mn
Sep 30, 2022 26.19 Mn
Jun 30, 2022 34.28 Mn
Mar 31, 2022 31.09 Mn
Dec 31, 2021 20.88 Mn
Sep 30, 2021 22.24 Mn
API Access

Fulcrum Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=FULC&period=max&api_key=YOUR_API_KEY